HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,669,709 | +6.1% | 452,599 | -6.7% | 0.01% | 0.0% |
| Q2 2023 | $17,594,005 | -5.3% | 485,218 | +53.6% | 0.01% | -25.0% |
| Q4 2022 | $18,585,532 | +6.5% | 315,973 | -26.8% | 0.01% | 0.0% |
| Q3 2022 | $17,450,000 | +1754.4% | 431,396 | +2051.1% | 0.01% | – |
| Q2 2022 | $941,000 | +26.1% | 20,055 | +8.1% | 0.00% | – |
| Q1 2022 | $746,000 | +1.4% | 18,545 | +2.8% | 0.00% | – |
| Q4 2021 | $736,000 | -84.4% | 18,047 | -84.8% | 0.00% | -100.0% |
| Q3 2021 | $4,713,000 | -15.1% | 118,749 | -2.0% | 0.00% | -33.3% |
| Q2 2021 | $5,553,000 | +8.8% | 121,193 | +0.3% | 0.00% | 0.0% |
| Q1 2021 | $5,102,000 | -32.6% | 120,890 | -31.8% | 0.00% | -40.0% |
| Q4 2020 | $7,574,000 | +36.9% | 177,146 | -15.1% | 0.01% | 0.0% |
| Q3 2020 | $5,531,000 | -9.8% | 208,708 | -4.7% | 0.01% | -16.7% |
| Q2 2020 | $6,133,000 | +74.9% | 219,075 | +5.4% | 0.01% | +50.0% |
| Q1 2020 | $3,507,000 | -0.2% | 207,933 | +4.9% | 0.00% | +33.3% |
| Q4 2019 | $3,515,000 | +140.6% | 198,247 | +110.6% | 0.00% | +200.0% |
| Q3 2019 | $1,461,000 | +1.2% | 94,122 | +12.0% | 0.00% | 0.0% |
| Q2 2019 | $1,443,000 | +35975.0% | 84,043 | +32224.2% | 0.00% | – |
| Q1 2019 | $4,000 | -86.7% | 260 | -87.1% | 0.00% | – |
| Q4 2018 | $30,000 | +42.9% | 2,011 | +80.4% | 0.00% | – |
| Q3 2018 | $21,000 | +10.5% | 1,115 | -2.7% | 0.00% | – |
| Q2 2018 | $19,000 | -62.0% | 1,146 | -55.1% | 0.00% | – |
| Q1 2018 | $50,000 | -2.0% | 2,550 | 0.0% | 0.00% | – |
| Q4 2017 | $51,000 | -97.5% | 2,550 | -97.8% | 0.00% | -100.0% |
| Q3 2017 | $2,060,000 | +8140.0% | 118,560 | +6049.4% | 0.00% | – |
| Q2 2017 | $25,000 | -44.4% | 1,928 | -45.4% | 0.00% | – |
| Q1 2017 | $45,000 | +9.8% | 3,529 | +3.3% | 0.00% | – |
| Q4 2016 | $41,000 | +127.8% | 3,415 | +123.5% | 0.00% | – |
| Q3 2016 | $18,000 | +260.0% | 1,528 | +189.4% | 0.00% | – |
| Q2 2016 | $5,000 | -95.5% | 528 | -95.5% | 0.00% | – |
| Q1 2016 | $110,000 | -45.5% | 11,656 | 0.0% | 0.00% | – |
| Q4 2015 | $202,000 | +1246.7% | 11,656 | +961.6% | 0.00% | – |
| Q3 2015 | $15,000 | 0.0% | 1,098 | +61.5% | 0.00% | – |
| Q2 2015 | $15,000 | -96.6% | 680 | -97.8% | 0.00% | -100.0% |
| Q1 2015 | $445,000 | +53.4% | 31,180 | +3.9% | 0.00% | – |
| Q4 2014 | $290,000 | +6.2% | 30,000 | 0.0% | 0.00% | – |
| Q3 2014 | $273,000 | -17.8% | 30,000 | -11.0% | 0.00% | – |
| Q2 2014 | $332,000 | -12.9% | 33,690 | +12.3% | 0.00% | – |
| Q1 2014 | $381,000 | -15.3% | 30,000 | 0.0% | 0.00% | -100.0% |
| Q4 2013 | $450,000 | +36.0% | 30,000 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $331,000 | +38.5% | 30,000 | 0.0% | 0.00% | – |
| Q2 2013 | $239,000 | – | 30,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |